Lantern Pharma Inc. (LTRN) › Capital ExpendituresLantern Pharma Inc. (LTRN) — Capital ExpendituresAnnual figures by period end, from SEC filings.2021-12-31: $15.5K2022-12-31: $27.8K2023-12-31: $18.7K2024-12-31: $12.6K2025-12-31: $1.7K$1.7K2021-12-31Capital Expenditures (USD)2025-12-31Period endedCapital ExpendituresChange YoYSource filing2025-12-31$1.7K-86.4%2026-03-30From 2025-01-012024-12-31$12.6K-32.8%2026-03-30From 2024-01-012023-12-31$18.7K-32.7%2025-03-27From 2023-01-012022-12-31$27.8K+79.7%2024-03-18From 2022-01-012021-12-31$15.5K—2023-03-20From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)